Carwin Pharm Assoc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CARWIN PHARM ASSOC
CARWIN PHARM ASSOC has two approved drugs.
There is one US patent protecting CARWIN PHARM ASSOC drugs.
There are twenty-eight patent family members on CARWIN PHARM ASSOC drugs in twenty-seven countries and two supplementary protection certificates in two countries.
Summary for Carwin Pharm Assoc
| International Patents: | 28 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Carwin Pharm Assoc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carwin Pharm Assoc | CLOTIC | clotrimazole | SOLUTION/DROPS;OTIC | 217628-001 | Sep 26, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Carwin Pharm Assoc | CLOTIC | clotrimazole | SOLUTION/DROPS;OTIC | 217628-001 | Sep 26, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Carwin Pharm Assoc | CLOTIC | clotrimazole | SOLUTION/DROPS;OTIC | 217628-001 | Sep 26, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Carwin Pharm Assoc | CLOTIC | clotrimazole | SOLUTION/DROPS;OTIC | 217628-001 | Sep 26, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Carwin Pharm Assoc | VYSCOXA | celecoxib | SUSPENSION;ORAL | 211759-001 | Jul 29, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Carwin Pharm Assoc | CLOTIC | clotrimazole | SOLUTION/DROPS;OTIC | 217628-001 | Sep 26, 2025 | RX | Yes | Yes | 12,246,006 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Carwin Pharm Assoc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 284858 | ⤷ Start Trial |
| San Marino | T202400262 | ⤷ Start Trial |
| Serbia | 65657 | ⤷ Start Trial |
| Japan | 7514844 | ⤷ Start Trial |
| Singapore | 11202107773R | ⤷ Start Trial |
| China | 113423382 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Carwin Pharm Assoc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2488169 | C202330042 | Spain | ⤷ Start Trial | PRODUCT NAME: COCRISTAL DE TRAMADOL, OPCIONALMENTE EN FORMA DE UNA SAL FISIOLOGICAMENTE ACEPTABLE, Y CELECOXIB; NATIONAL AUTHORISATION NUMBER: 89051; DATE OF AUTHORISATION: 20230925; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 89051; DATE OF FIRST AUTHORISATION IN EEA: 20230925 |
| 0731795 | 10075033 | Germany | ⤷ Start Trial | PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
